Maartje J Hooning

10PUBLICATIONS
149CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersCancer geneticsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 13, 2025
Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women.

Peh Joo Ho, Christine Kim Yan Loo, Ryan Jak Yang Lim

|Jun 04, 2025
Breast Density Changes after Risk-Reducing Salpingo-oophorectomy in Women with a Pathogenic Germline Variant in BRCA1 or BRCA2.

Elizabeth A Loehrer, Frederieke H van der Baan, Thea M Mooij

|Nov 23, 2024
High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers.

Iris A S Stroot, Joost Bart, Harry Hollema

|Jan 11, 2024
Expression and Localization of Ferritin-Heavy Chain Predicts Recurrence for Breast Cancer Patients with a BRCA1/2 Mutation.

Shuoying Qu, A Mieke Timmermans, Bernadette A M Heemskerk-Gerritsen

|Jul 04, 2023
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.

Anna Morra, Maartje A C Schreurs, Irene L Andrulis

|Jun 27, 2023
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation.

Mark van Barele, Delal Akdeniz, Bernadette A M Heemskerk-Gerritsen

Pageof 2

Frequent Collaborators

3 joint publications

Christoph Engel

3 joint publications

Thilo Dörk

3 joint publications

Douglas F Easton

3 joint publications

Marjanka K Schmidt